Nonmyeloablative conditioning followed by allogeneic transplantation has a better outcome than high-dose chemotherapy plus autografting in non Hodgkin lymphomas with T-cell histology.

被引：0
|
作者：
Corradini, P
Dodero, A
Zallio, F
Caracciolo, D
Ciceri, F
Cuttica, A
Gianni, AM
Pileri, A
Tarella, C
机构：
[1] Univ Milan, Ist Nazl Tumori, Hematol BMT Unit, I-20122 Milan, Italy
[2] Univ Turin, I-10124 Turin, Italy
[3] Hosp San Raffaele, I-20132 Milan, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1654
引用
收藏
页码：427A / 427A
页数：1
相关论文
共 50 条
  • [1] Reduced-intensity conditioning followed by allogeneic transplantation has a better outcome than high-dose chemotherapy plus autografting in T-cell non-Hodgkin's lymphoma
    Corradini, P
    Dodero, A
    Zallio, F
    Dinicola, M
    Caracciolo, D
    Ciceri, F
    Cuttica, A
    Boccadoro, M
    Gianni, A
    Pileri, A
    Tarella, C
    BONE MARROW TRANSPLANTATION, 2003, 31 : S67 - S67
  • [2] Graft-versus-lymphoma effect in peripheral T-cell lymphomas (PTCL): Reduced-intensity conditioning followed by allogeneic transplantation gives a better outcome than high-dose chemotherapy followed by autografting.
    Corradini, P
    Dodero, A
    Zallio, F
    Cuttica, A
    Caracciolo, D
    Di Nicola, M
    Casini, M
    Ciceri, F
    Narni, F
    Patriarca, F
    Boccadoro, M
    Gianni, AM
    Tarella, C
    BLOOD, 2003, 102 (11) : 900A - 901A
  • [3] Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation
    C. Kahl
    M. Leithäuser
    D. Wolff
    B. Steiner
    G. Hartung
    J. Casper
    M. Freund
    Annals of Hematology, 2002, 81 : 646 - 650
  • [4] Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation
    Kahl, C
    Leithäuser, M
    Wolff, D
    Steiner, B
    Hartung, G
    Casper, J
    Freund, M
    ANNALS OF HEMATOLOGY, 2002, 81 (11) : 646 - 650
  • [5] Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant
    Jagasia, M
    Morgan, D
    Goodman, S
    Hamilton, K
    Kinney, M
    Shyr, Y
    Stein, R
    Zic, J
    Greer, J
    LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2261 - 2267
  • [6] High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma
    Provencio, Mariano
    Fayad, Luis E.
    MEDICINA CLINICA, 2008, 130 (02): : 60 - 65
  • [7] High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma
    Law, Lisa Y.
    Horning, Sandra J.
    Wong, Ruby M.
    Johnston, Laura J.
    Laport, Ginna G.
    Lowsky, Robert
    Shizuru, Judith A.
    Blume, Karl G.
    Negrin, Robert S.
    Stockerl-Goldstein, Keith E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (07) : 703 - 711
  • [8] High-dose chemotherapy followed by autologous stem-cell transplantation for Hodgkin disease using CVB as conditioning regimen
    Avila, R. A.
    Valdez, J. A.
    Caeiro, G.
    Basquiera, A. L.
    Sturich, A. G.
    Berretta, A. R.
    Garcia, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow
    Santini, G
    De Souza, C
    Congiu, AM
    Marino, G
    Nati, S
    Damasio, E
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 131 - 131
  • [10] High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow
    Santini, G
    De Souza, C
    Congiu, AM
    Nati, S
    Marino, G
    Soracco, M
    Sertoli, MR
    Rubagotti, A
    Spriano, M
    Vassallo, F
    Rossi, E
    Vimercati, R
    Piaggio, G
    Figari, O
    Benvenuto, F
    Abate, M
    Truini, M
    Ravetti, JL
    Ribizzi, I
    Damasio, E
    LEUKEMIA & LYMPHOMA, 1999, 33 (3-4) : 321 - 330
12345